Quest Diagnostics Incorporated (NYSE:DGX) on Tuesday reported upbeat earnings for the first quarter on Tuesday.
The company posted first-quarter adjusted earnings of $2.50 per share, beating the consensus of $2.35. The provider of diagnostic information services reported sales of $2.895 billion, up 9.2% year over year, beating the consensus of $2.827 billion. Consolidated organic revenues grew by 9%.
“During the first quarter, we grew revenues over 9%, almost entirely from organic revenue growth, on broad-based demand for our clinical innovations, expansion into new clinical areas, and collaborations with elite healthcare and consumer health organizations,” said Jim Davis, Chairman, CEO, and President.
Quest Diagnostics raised fiscal 2026 adjusted earnings per share guidance from $10.50-$10.70 to …
This post was originally published here
